Related Experiment Videos
Vascular smooth muscle and nitric oxide synthase
Igor B Buchwalow1, Thomas Podzuweit, Werner Bocker
1Department of Medicine B, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany. buchwalo@uni-muenster.de
Summary
Vascular smooth muscle cells (VSMCs) express nitric oxide synthase (NOS), challenging the traditional view. This local NOS expression offers a new pathway for regulating vascular function independently of the endothelium.
Area of Science:
- Vascular Biology
- Cellular Biology
- Biochemistry
Background:
- The established concept of endothelium-derived relaxing factor (EDRF) posits nitric oxide (NO) production solely by endothelial cells.
- This model suggests vascular smooth muscle cells (VSMCs) lack nitric oxide synthase (NOS) expression.
- Recent findings have prompted debate regarding this traditional view of NO regulation in blood vessels.
Purpose of the Study:
- To investigate the expression of NOS isoforms within VSMCs.
- To challenge the prevailing understanding of NO's role in vascular tone and proliferation.
- To explore alternative mechanisms of vascular regulation.
Main Methods:
- Utilized a novel supersensitive immunocytochemical technique with tyramide signal amplification.
- Employed electron microscopic immunogold labeling for high-resolution visualization.
- Complemented with Western blotting analysis to confirm protein expression.
Main Results:
- Provided the first evidence that VSMCs express all three NOS isoforms.
- Demonstrated that NOS isoform expression varies depending on the specific blood vessel type.
- Contradicted the long-held belief that VSMCs do not express NOS.
Conclusions:
- VSMCs possess the intrinsic capacity to produce NO through NOS expression.
- Local NOS expression in VSMCs offers a potential mechanism for endothelium-independent modulation of vascular functions.
- These findings necessitate a re-evaluation of NO's role in vascular physiology and pathophysiology.